Top Markets
#1 GEKKO GEKKO +48.56%
#2 ADO Protocol ADO Protocol +38.93%
#3 Pons Pons +37.74%
#4 Prom Prom +30.26%
#5 TENDIES TENDIES +29.63%
#6 Helium Helium +29.05%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.11%
#8 Collect on Fanable Collect on Fanable +17.96%
#9 Main Street Yield Main Street Yield +17.48%
#10 o1.exchange o1.exchange +17.01%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Rank in Stocks #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Share Price
$61.73
Last synced: 2026-08-28
Market Cap
$1.01B
Change (1 day)
-1.02%
Change (1 year)
5.10%
Country
DK
Trade Gubra A/S (GUBRA)

Category

Healthcare
Stock price history for Gubra A/S (GUBRA)
Highest end of day price: $60.73 on 2026-08-01

Lowest end of day price: $16.05 on 2023-04-01
Stock price history of Gubra A/S from 2023 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -19.73%
2025 -18.20%
2024 437.82%
2023 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH